Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Avricore Health ( (TSE:AVCR) ).
On January 12, 2026, Avricore Health Inc. filed a Form 6-K with the U.S. Securities and Exchange Commission covering December 2025, furnishing investors with its interim financial statements and management’s discussion and analysis for the period ended September 30, 2025, along with CEO and CFO certifications dated December 1, 2025 attesting to the fairness and accuracy of those filings. As a venture issuer using the basic certification regime under National Instrument 52-109, the company notes that these certificates do not extend to representations about disclosure controls and procedures or internal control over financial reporting, a limitation that may imply additional risk around the robustness of its reporting systems compared with larger non-venture issuers, even as management asserts the interim results are fairly presented in all material respects.
The most recent analyst rating on (TSE:AVCR) stock is a Hold with a C$0.05 price target. To see the full list of analyst forecasts on Avricore Health stock, see the TSE:AVCR Stock Forecast page.
Spark’s Take on TSE:AVCR Stock
According to Spark, TipRanks’ AI Analyst, TSE:AVCR is a Neutral.
The score is driven primarily by weak financial performance (TTM revenue contraction, deep losses, and a return to free cash flow burn). Technicals are also soft with the price below major moving averages and slightly negative MACD. Valuation remains constrained by a negative P/E and no provided dividend yield.
To see Spark’s full report on TSE:AVCR stock, click here.
More about Avricore Health
Avricore Health Inc. is a Canadian foreign private issuer listed in the United States, operating as a venture issuer and filing under international and Canadian securities regulations, with its principal executive office in Vancouver, British Columbia.
Average Trading Volume: 71,196
Technical Sentiment Signal: Sell
Current Market Cap: C$5.06M
See more data about AVCR stock on TipRanks’ Stock Analysis page.